• Clasto-Lactacystin β-lactone in RIPK3 Research

  2026-08-09

  Clasto-Lactacystin β-lactone provides a powerful way to test whether RIPK3 loss is proteasome-dependent during virus-induced necroptosis. This article translates a landmark host–virus study into a rigorous assay strategy while clarifying what pharmacological proteasome blockade can—and cannot—prove.

• MK-5108 (VX-689) in Aurora A Research

  2026-08-08

  MK-5108 (VX-689) combines subnanomolar Aurora A potency with substantially weaker Aurora B and C activity, making it useful for mechanistic cell-cycle studies and cancer cell line proliferation assays. This workflow-focused guide shows how to prepare, deploy, interpret, and troubleshoot the compound while translating new retinoblastoma evidence into testable research strategies.

• Annexin V-PE Reagent for CAR-T Cell Death Assays

  2026-08-07

  The Annexin V-PE Reagent provides a rapid phosphatidylserine externalization readout for distinguishing early apoptotic events from later loss of membrane integrity. In CD38 CAR-T studies, it can complement cytotoxicity measurements by tracking target-cell killing, T-cell fratricide, and construct-dependent safety signals in the same experimental workflow.

• Cytochalasin D: Advancing Cellular Uptake and Cancer Researc

  2026-08-07

  This thought-leadership article explores how Cytochalasin D, a potent actin polymerization inhibitor, is redefining translational research in cancer biology and ocular drug delivery. Integrating mechanistic insights and practical guidance, we bridge experimental validation with the strategic design of nanoparticle-based therapies, referencing the latest findings on cellular uptake pathways in human corneal epithelial cells. Researchers will find actionable protocol recommendations, an honest appraisal of cross-domain applications, and a forward-looking vision for precision cell modeling.

• Amphotericin B: Mechanistic Innovation and Synergy in Fungal

  2026-08-06

  Explore how Amphotericin B, a leading polyene antifungal antibiotic, drives innovation in fungal infection research through membrane-targeted mechanisms and new synergistic strategies. This article uniquely examines mechanistic advances and translational considerations for advanced antifungal assay design.

• NLRP10 Regulates Keratinocyte Survival and Differentiation i

  2026-08-06

  The referenced study identifies NLRP10 as a critical regulator of epidermal barrier integrity in atopic dermatitis (AD), promoting keratinocyte survival and P63-dependent differentiation. These findings clarify the mechanistic basis for genetic associations between NLRP10 and AD, suggesting new directions for therapeutic intervention targeting skin homeostasis.

• KR-12: Mechanistic Insights and Strategic Impact for Transla

  2026-08-05

  KR-12, the smallest active fragment of human LL-37, is redefining the landscape for antimicrobial and anti-biofilm research. This article explores KR-12’s unique mechanism of action, validated efficacy against multidrug-resistant pathogens, and its translational potential, offering strategic guidance for researchers aiming to bridge discovery and clinical impact.

• Sodium phosphate dibasic: Precision Buffer for Molecular Ass

  2026-08-05

  Sodium phosphate dibasic (Na2HPO4) is a highly water-soluble inorganic salt, vital for pH stabilization in biological assay buffers. Its reproducible buffering capacity underpins rigorous molecular biology and aquatic toxicity testing. Supplied at ≥98% purity by APExBIO, it is indispensable for reproducibility and workflow reliability.

• Translational Leverage: SU5416 in Vascular and Immune Modula

  2026-08-04

  This thought-leadership piece explores how SU5416 (Semaxanib) enables translational researchers to dissect and manipulate angiogenesis, vascular remodeling, and immunomodulation. By integrating new biomechanical insights from pulmonary hypertension studies and strategic protocol guidance, it provides a roadmap for maximizing scientific and clinical impact, with a focus on experimental rigor and future research horizons.

• Adiponectin Attenuates Post-Splenectomy Cognitive Deficits v

  2026-08-04

  This study demonstrates that adiponectin administration significantly reduces cognitive impairment following splenectomy in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB signaling pathway. The findings provide mechanistic insight into perioperative neurocognitive disorder (PND) and highlight potential molecular targets for intervention.

• Chloroquine in Research: Applied Protocols and Troubleshooti

  2026-08-03

  Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) is more than an anti-inflammatory agent for malaria research—its versatility as an autophagy and Toll-like receptor inhibitor drives innovation in oncology, immunology, and virology. This guide decodes applied workflows, key advances, and troubleshooting strategies for maximizing reliability and translational value in the lab.

• Catalpol Induces Osteoclast Apoptosis via Sirt6-ERα-FasL in

  2026-08-03

  This study reveals that Catalpol attenuates postmenopausal osteoporosis in ovariectomized rats by promoting osteoclast apoptosis through the Sirt6-ERα-FasL pathway. The findings provide mechanistic insight into Catalpol’s anti-osteoporotic action and inform research design for osteoporosis animal models.

• PP2A-Mediated Autophagy Drives Candida albicans Biofilm Resi

  2026-08-02

  This study uncovers that protein phosphatase 2A (PP2A) regulates drug resistance in Candida albicans biofilms via autophagy-related protein phosphorylation. The findings highlight PP2A's central role in modulating both biofilm formation and antifungal susceptibility, informing targeted strategies for fungal infection research.

• 12-O-tetradecanoyl Phorbol-13-acetate: Precision ERK/MAPK Ac

  2026-08-01

  12-O-tetradecanoyl phorbol-13-acetate (TPA) is a benchmark ERK/MAPK pathway activator, proven in both cancer and neurobiology models. Here, we detail optimized workflows, troubleshooting insights, and how the latest mechanistic discoveries elevate TPA’s value in signal transduction research.

• Monomeric Amyloid Beta-Peptide (1-40) Suppresses Microglial

  2026-07-31

  This article examines recent evidence showing that monomeric Amyloid Beta-Peptide (1-40) (human) acts as a negative regulator of microglial inflammatory activity via an APP/heterotrimeric G protein pathway. The findings challenge conventional views of amyloid beta's role in Alzheimer's disease, revealing a nuanced, context-dependent function with implications for neuroinflammation research.

528 records 7/36 page Previous Next First page 上5页 678910 下5页 Last page